News Conference News EAS 2023 With New LDL Goalposts in FH, Combo Therapy Must Start Early Michael O'Riordan May 29, 2023
News Conference News EAS 2023 Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH Michael O'Riordan May 26, 2023
News Conference News SCAI 2023 Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis L.A. McKeown May 22, 2023
News Conference News EuroPCR 2023 Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization Michael O'Riordan May 19, 2023
News Conference News SCAI 2023 DIPRA Quells Fears Over Distal Radial Cath and Hand Function at 1 Year L.A. McKeown May 19, 2023
Presentation EuroPCR 2023 BIOADAPTOR RCT: Randomized Controlled Trial of Sirolimus-Eluting Bioadaptor Scaffold Versus Zotarolimus-Eluting Drug-Eluting Stent Presenter: Shigeru Saito May 18, 2023
News Conference News EuroPCR 2023 ‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise Michael O'Riordan May 18, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News To Boost Access and Outcomes With New PCI Centers, Location Matters L.A. McKeown May 08, 2023
News Daily News Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA Michael O'Riordan May 03, 2023
News Daily News Rehospitalizations After Acute MI: Young Women Outpace Young Men L.A. McKeown May 03, 2023
News Daily News Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes Michael O'Riordan May 01, 2023
News Daily News Physiologic Testing May ID Patients Who’ll Still Have Angina After PCI Michael O'Riordan March 31, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023